Investing in innovation in health: A new industrial strategy for the COVID-19 era Virtual event
Join Friends of Europe for an online debate Investing in innovation in health: A new industrial strategy for the COVID-19 era on Thursday 10 December from 10.00 to 11.00 CET.
Engage directly with Christophe Grudler, Member of the European Parliament’s Committee on Industry, Research and Energy (ITRE); George Katzourakis, Senior Vice President and Head of Europe at GlaxoSmithKline (GSK); Despina Spanou, Head of Cabinet of European Commissioner for Promoting our European Way of Life Schinas, as well as industry representatives and European policy makers.
Europe is home to world-leading pharmaceutical and med-tech companies and is the continent with the most cost-effective provision of universal healthcare. The 2021 EU’s industrial strategy update represents a huge potential for the health sector to be a motor of sustainable recovery.
- How can a new industrial strategy help boost the EU's health sector?
- What policy measures should be considered along the recovery funding package and recently announced EU-BARDA agency for biomedical research and development so to not miss the opportunity to make Europe the Silicon Valley for research and innovation?
- What are the appropriate incentives for private sector investment medical innovation?
>> Register for the event or decline the invitation here
>> See the latest programme
You will receive a confirmation of your registration with log-on details prior to the event.
This event is co-organised with EFPIA.